RhumbLine Advisers’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.71M | Buy |
210,355
+27,446
| +15% | +$223K | ﹤0.01% | 1972 |
|
2025
Q1 | $1.44M | Buy |
182,909
+23,645
| +15% | +$186K | ﹤0.01% | 1985 |
|
2024
Q4 | $2.37M | Sell |
159,264
-2,571
| -2% | -$38.3K | ﹤0.01% | 1793 |
|
2024
Q3 | $2.47M | Sell |
161,835
-4,000
| -2% | -$61.2K | ﹤0.01% | 1794 |
|
2024
Q2 | $2.53M | Sell |
165,835
-6,838
| -4% | -$104K | ﹤0.01% | 1767 |
|
2024
Q1 | $3.26M | Buy |
172,673
+1,335
| +0.8% | +$25.2K | ﹤0.01% | 1651 |
|
2023
Q4 | $3.27M | Buy |
171,338
+1,489
| +0.9% | +$28.4K | ﹤0.01% | 1655 |
|
2023
Q3 | $3.05M | Buy |
169,849
+4,063
| +2% | +$72.9K | ﹤0.01% | 1630 |
|
2023
Q2 | $3.37M | Sell |
165,786
-295
| -0.2% | -$5.99K | ﹤0.01% | 1614 |
|
2023
Q1 | $3.03M | Buy |
166,081
+3,044
| +2% | +$55.5K | ﹤0.01% | 1594 |
|
2022
Q4 | $3.37M | Buy |
163,037
+4,682
| +3% | +$96.8K | ﹤0.01% | 1519 |
|
2022
Q3 | $4.14M | Buy |
158,355
+12,608
| +9% | +$330K | 0.01% | 1345 |
|
2022
Q2 | $3.69M | Buy |
145,747
+84,927
| +140% | +$2.15M | 0.01% | 1426 |
|
2022
Q1 | $1.92M | Sell |
60,820
-4,597
| -7% | -$145K | ﹤0.01% | 1835 |
|
2021
Q4 | $2.65M | Sell |
65,417
-86
| -0.1% | -$3.48K | ﹤0.01% | 1730 |
|
2021
Q3 | $2.28M | Sell |
65,503
-25
| -0% | -$872 | ﹤0.01% | 1832 |
|
2021
Q2 | $1.8M | Buy |
65,528
+17,755
| +37% | +$487K | ﹤0.01% | 2001 |
|
2021
Q1 | $1.34M | Sell |
47,773
-3,588
| -7% | -$101K | ﹤0.01% | 2074 |
|
2020
Q4 | $1.33M | Buy |
51,361
+5,126
| +11% | +$133K | ﹤0.01% | 2021 |
|
2020
Q3 | $792K | Sell |
46,235
-2,687
| -5% | -$46K | ﹤0.01% | 2083 |
|
2020
Q2 | $1.21M | Sell |
48,922
-5,436
| -10% | -$134K | ﹤0.01% | 1965 |
|
2020
Q1 | $754K | Buy |
54,358
+5,145
| +10% | +$71.4K | ﹤0.01% | 2004 |
|
2019
Q4 | $497K | Buy |
49,213
+354
| +0.7% | +$3.58K | ﹤0.01% | 2365 |
|
2019
Q3 | $445K | Buy |
48,859
+4,660
| +11% | +$42.4K | ﹤0.01% | 2384 |
|
2019
Q2 | $351K | Buy |
44,199
+4,664
| +12% | +$37K | ﹤0.01% | 2528 |
|
2019
Q1 | $494K | Sell |
39,535
-307
| -0.8% | -$3.84K | ﹤0.01% | 2335 |
|
2018
Q4 | $429K | Buy |
+39,842
| New | +$429K | ﹤0.01% | 2367 |
|